Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-25 @ 9:31 PM
Study NCT ID:
NCT02383251
Status:
COMPLETED
Last Update Posted:
2023-09-06
First Post:
2015-03-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer
Sponsor:
ARCAGY/ GINECO GROUP
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-15
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-04
First Submit QC Date:
None
Study First Post Date:
2015-03-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-05
Last Update Post Date:
2023-09-06
Last Update Post Date Type:
ACTUAL